← Leaderboards
Richard A Koup
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteVaccinesImmune ResponseVaccinationInfectionHiv InfectionsB-LymphocytesAntigensCd4 Positive T LymphocytesVirusPathogenVaccine DevelopmentLymph NodesResponseChronicNonhuman PrimateImmuneClinical TrialsT Cell ResponseNeutralizing AntibodyIn VivoProgramsCharacteristicsAntibodies
Grant awards (102)
Vaccine Immunology Program$6,901,965
ZIA · FY2025 · AI · contact PI
HIV/SIV Replication In Vivo$1,447,716
ZIA · FY2025 · AI · contact PI
Immune correlates of protection$1,135,344
ZIA · FY2025 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,013,717
ZIA · FY2025 · AI · contact PI
Deoxyuracil as a marker of replication-competent proviruses$540,000
ZIA · FY2025 · AI · contact PI
HIV/SIV Replication In Vivo$1,429,323
ZIA · FY2024 · AI · contact PI
Immune correlates of protection$1,029,324
ZIA · FY2024 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,029,324
ZIA · FY2024 · AI · contact PI
T cell analysis of COVID infection and vaccination$629,324
ZIA · FY2024 · AI · contact PI
HIV/SIV Replication In Vivo$1,458,648
ZIA · FY2023 · AI · contact PI
Immune correlates of protection$1,243,986
ZIA · FY2023 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,143,986
ZIA · FY2023 · AI · contact PI
T cell analysis of COVID infection and vaccination$223,224
ZIA · FY2023 · AI · contact PI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases$2,480,852
ZIC · FY2022 · AI · contact PI
Pre-clinical Vaccine Development for Respiratory Viruses$2,480,852
ZIC · FY2022 · AI · contact PI
HIV/SIV Replication In Vivo$1,401,317
ZIA · FY2022 · AI · contact PI
Immune correlates of protection$1,301,316
ZIA · FY2022 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,143,986
ZIA · FY2022 · AI · contact PI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines$892,443
ZIC · FY2022 · AI · contact PI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants$892,443
ZIA · FY2022 · AI · contact PI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)$285,362
ZIC · FY2022 · AI · contact PI
T cell analysis of COVID infection and vaccination$223,224
ZIA · FY2022 · AI · contact PI
Immune correlates of protection$1,526,197
ZIA · FY2021 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,496,217
ZIA · FY2021 · AI · contact PI
HIV/SIV Replication In Vivo$1,401,317
ZIA · FY2021 · AI · contact PI
T cell analysis of COVID infection and vaccination$201,768
ZIA · FY2021 · AI · contact PI
Immune correlates of protection$1,542,573
ZIA · FY2020 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,385,242
ZIA · FY2020 · AI · contact PI
HIV/SIV Replication In Vivo$1,321,945
ZIA · FY2020 · AI · contact PI
T cell analysis of COVID infection and vaccination$150,000
ZIA · FY2020 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$2,209,941
ZIA · FY2019 · AI · contact PI
Immune correlates of protection$1,657,456
ZIA · FY2019 · AI · contact PI
HIV/SIV Replication In Vivo$1,657,456
ZIA · FY2019 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,778,916
ZIA · FY2018 · AI · contact PI
HIV/SIV Replication In Vivo$1,334,187
ZIA · FY2018 · AI · contact PI
Immune correlates of protection$1,334,187
ZIA · FY2018 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$2,210,762
ZIA · FY2017 · AI · contact PI
Immune correlates of protection$1,970,186
ZIA · FY2017 · AI · contact PI
HIV/SIV Replication In Vivo$1,757,804
ZIA · FY2017 · AI · contact PI
NIAID Vaccine Immune T cell and Antibody Laboratory Core$4,846,399
ZIC · FY2016 · AI · contact PI
Immunology Core$2,022,247
ZIC · FY2016 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,479,880
ZIA · FY2016 · AI · contact PI
HIV/SIV Replication In Vivo$1,479,878
ZIA · FY2016 · AI · contact PI
Immune correlates of protection$1,469,877
ZIA · FY2016 · AI · contact PI
NIAID Vaccine Immune T cell and Antibody Laboratory Core$3,175,588
ZIC · FY2015 · AI · contact PI
Immunology Core$2,016,247
ZIC · FY2015 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,273,880
ZIA · FY2015 · AI · contact PI
HIV/SIV Replication In Vivo$1,273,878
ZIA · FY2015 · AI · contact PI
Immune correlates of protection$1,263,877
ZIA · FY2015 · AI · contact PI
NIAID Vaccine Immune T cell and Antibody Laboratory Core$3,024,370
ZIC · FY2014 · AI · contact PI
Immunology Core$2,016,247
ZIC · FY2014 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,273,880
ZIA · FY2014 · AI · contact PI
HIV/SIV Replication In Vivo$1,273,878
ZIA · FY2014 · AI · contact PI
Immune correlates of protection$1,263,877
ZIA · FY2014 · AI · contact PI
NIAID Vaccine Immune T cell and Antibody Laboratory Core$4,100,903
ZIC · FY2013 · AI · contact PI
Tfh and B cells in HIV/SIV pathogenesis and vaccination$1,273,880
ZIA · FY2013 · AI · contact PI
HIV/SIV Replication In Vivo$1,273,878
ZIA · FY2013 · AI · contact PI
Immune correlates of protection$1,263,878
ZIA · FY2013 · AI · contact PI
Immunology Core$339,948
ZIC · FY2013 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$1,273,880
ZIA · FY2012 · AI · contact PI
Immune Reconstitution$1,273,879
ZIA · FY2012 · AI · contact PI
HIV Infection In Vivo And In Vitro$1,273,878
ZIA · FY2012 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine Research$1,263,878
ZIA · FY2012 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$1,273,880
ZIA · FY2011 · AI · contact PI
Immune Reconstitution$1,273,879
ZIA · FY2011 · AI · contact PI
HIV Infection In Vivo And In Vitro$1,273,878
ZIA · FY2011 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine Research$1,263,878
ZIA · FY2011 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$1,282,212
ZIA · FY2010 · AI · contact PI
Immune Reconstitution$1,282,211
ZIA · FY2010 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine Research$1,282,211
ZIA · FY2010 · AI · contact PI
HIV Infection In Vivo And In Vitro$1,282,210
ZIA · FY2010 · AI · contact PI
ARRA: Development of Universal Influenza Assays$851,102
ZIA · FY2010 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$1,596,278
ZIA · FY2009 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine Research$1,596,277
ZIA · FY2009 · AI · contact PI
Immune Reconstitution$399,070
ZIA · FY2009 · AI · contact PI
HIV Infection In Vivo And In Vitro$399,070
ZIA · FY2009 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine Research$1,413,801
Z01 · FY2008 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$1,413,801
Z01 · FY2008 · AI · contact PI
HIV Infection In Vivo And In Vitro$666,391
Z01 · FY2008 · AI · contact PI
Immune Reconstitution$666,391
Z01 · FY2008 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$1,213,840
Z01 · FY2007 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine Research$1,213,840
Z01 · FY2007 · AI · contact PI
HIV Infection In Vivo And In Vitro$1,213,839
Z01 · FY2007 · AI · contact PI
Immune Reconstitution$1,213,839
Z01 · FY2007 · AI · contact PI
HIV Infection In Vivo And In Vitro$0
Z01 · FY2006 · AI · contact PI
Testing of Blood Samples for Immune Response and Vaccine$0
Z01 · FY2006 · AI · contact PI
T Cell Immune Responses To HIV And Other Pathogens$0
Z01 · FY2006 · AI · contact PI
Immune Reconstitution$0
Z01 · FY2006 · AI · contact PI
HIV Infection In Vivo And In Vitro$0
Z01 · FY2005 · AI
Testing of Blood Samples for Immune Response /Vaccine$0
Z01 · FY2005 · AI
T Cell Immune Responses To HIV And Other Pathogens$0
Z01 · FY2005 · AI
Immune Reconstitution$0
Z01 · FY2005 · AI
HIV Infection In Vivo And In Vitro$0
Z01 · FY2004 · AI
Testing Blood for Immune Response and Vaccine Research$0
Z01 · FY2004 · AI
T Cell Immune Responses To HIV And Other Pathogens$0
Z01 · FY2004 · AI
Immune Reconstitution$0
Z01 · FY2004 · AI
Hiv Infection In Vivo And In Vitro$0
Z01 · FY2003 · AI
T Cell Immune Responses To Hiv And Other Pathogens$0
Z01 · FY2003 · AI
Immune Reconstitution$0
Z01 · FY2003 · AI
Hiv Infection In Vivo And In Vitro$0
Z01 · FY2002 · AI
T Cell Immune Responses To Hiv And Other Pathogens$0
Z01 · FY2002 · AI
Immune Reconstitution$0
Z01 · FY2002 · AI